10 - 12 April 2024

Vienna BioCenter, Austria

The 9th Probabilistic Modeling in Genomics Conference (ProbGen24), will be held in Vienna, Austria, April 10-12 2024, at the Vienna BioCenter

The conference will cover probabilistic models, algorithms, and statistical methods across a broad range of applications in genetics and genomics. We invite abstract submissions on a range of topics including ranging from phylogeny and population genetics to single cell -omics and machine learning in cancer biology. For an idea of the topics covered, please see the programs of previous meetings, which have been alternating between CSHL (2023, 2021, 2018, 2015), and locations in Europe (Oxford 2022, 2016, Aussois 2019, and Aarhus 2017).

Alongside invited speakers, oral presentations will be selected from submitted abstracts. Deadline for submission is 31st January, 2024. We particularly encourage abstract submissions from junior investigators, including postdoctoral fellows and graduate students. We will apply for funds from government and industry to partially support the travel expenses of selected speakers who would otherwise not be able to attend. 

The 2024 sessions include the following topics:

Genome evolution
Population genetics
ARGs and whole-genome analysis
Mutation and recombination
System biology


Registration will open soon. To stay informed about ProbGen2024 please provide us with your email adress here.

We will regularly update this website with new details on speakers, registration, poster sessions, sponsors and networking opportunities.

If you have any questions, please feel free to contact us.


Andrew Clark, Cornell University

Mercedes Pascual, New York University

Shamil Sunyaev, Harvard Medical School

CONFIRMED CHAIRS (more to come)
Anne-Florence Bitbol, EPFL, Lausanne

Mikkel Heide Schierup, Aarhus University

Sebastian Höhna, Ludwig-Maximilians-University, Munich

Denise Kühnert, Max Planck Institute of Geoanthropology, Jena

M. Elise Lauterbur, University of Arizona

Pier Palamara, Oxford University

Molly Przeworski, Columbia University

Oliver Stegle, Deutsches Krebsforschungszentrum, Heidelberg

Scientific organizers

Nick Barton, ISTA • Joachim Hermisson, University of Vienna • Carolin Kosiol, St. Andrews University • Magnus Nordborg, GMI